English
简体中文
About Us
Our Team
Development Strategy
Technology
Targeted Radionuclide Drug Conjugates
Theranostics Integrated
Production and Operation
Pipeline
PSMA
FAP
More
News Center
Contact Us
Industry News
Company News
14
11
2024-07
In 2030 the overall 5-year survival rate for cancer would reach 46.6%
Total 1 record(s)
1
